Biosimilars Landscape and FDA Regulatory Expectations

Biosimilars Landscape and FDA Regulatory Expectations
The Congressional Budget Office (CBO) has estimated that the United States could save $25 billion from the use of biosimilars over 10 years, and according to analysis the worldwide market for biosimilars will grow to $3.7 billion by 2015

Please note: That all fields marked with an asterisk (*) are required.